Get In Touch

Primary aldosteronism is a hormonal disorder that leads to high blood pressure. In primary aldosteronism, high levels of aldosterone hormone are produced, causing increased levels of sodium and low levels of potassium in the body. High levels of sodium in the blood lead to high volume of blood and ultimately high blood pressure. Primary aldosteronism is caused due to a growth of a benign tumor on the adrenal cortex. The condition is known as adrenocortical adenoma or Conn’s syndrome. Aldosterone receptor antagonists drugs are used as the first line of treatment for the management of symptoms of primary aldosteronism.

The primary aldosteronism treatment market is projected to be primarily driven by the rise in incidence rates of primary aldosterone disorder across the globe. Primary aldosterone disorders are mainly caused by Conn’s syndrome and over activity of the adrenal glands.

Easy availability and low cost of diagnostics test for primary aldosterone disorders such as oral salt loading tests, saline infusion tests, and fludrocortisone suppression tests, etc. are likely to drive the expansion of the primary aldosteronism treatment market during the forecast period. On the other hand, side effects of therapeutic drugs such as decreased sexual desire, impotence, menstrual irregularities in women, male breast enlargement, etc. are anticipated to restrain the market in the near future.

The global primary aldosteronism treatment market can be segmented based on drug class, distribution channel, and geography. In terms of drugs class, the global primary aldosteronism treatment market can be classified into aldosterone receptor antagonists and potassium sparring diuretics. Aldosterone receptor antagonists, also known as antimineralocorticoids, are a group of medicines that are used to block the effects of the aldosterone hormone produced in the adrenal gland. Aldosterone drugs stimulate/increase the sodium reabsorption activity of the kidneys, salivary glands, and sweat glands. Aldosterone receptor antagonists drugs block the reabsorption of sodium and thus decrease blood pressure. The aldosterone receptor antagonists segment is estimated to hold a leading primary aldosteronism treatment market share by the end of 2026 owing to increased usage of aldosterone drugs as the first line of treatment and easy availability and low cost of drugs. Aldolactone and CaroSpir are the most commonly used drugs for the treatment of primary aldosteronism.  In terms of distribution channel, the global primary aldosteronism treatment market can be categorized into hospital pharmacy, retail pharmacy, and online pharmacy store.

Based on geography, the global primary aldosteronism treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to hold a prominent share of the global primary aldosteronism treatment market owing to high prevalence of adrenal adenoma, a benign tumor of adrenal cortex; easy availability and low cost of drugs; and well-established health care facilities in the region. Europe is projected to constitute a key share of the global primary aldosteronism treatment market by the end of 2026. The primary aldosteronism treatment market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, owing to rapidly increasing number of patients with primary aldosterone disorder in China, India, and Japan; increasing adoption of a western life style;  changing health care infrastructure in the region; and easy availability of therapeutic drugs.

The global primary aldosteronism treatment market is highly fragmented, with a large number of manufactures holding a prominent share in various regions. Key players operating in the global primary aldosteronism treatment market include Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Accord Healthcare, Novartis AG, Concordia International Corp., Apotex Inc.,and  Allergan plc.,.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Primary Aldosteronism Treatment Market

Pre Book